Skip to content
Exits and Outcomes
Sign In
Subscribe
Digital health research, news, and analysis from Brian Dolan.
Prescription Digital Therapeutics
All Newsletters
224 articles
18 of 23
Pharma execs talk digital therapeutic pricing. Germany reimburses first two prescribable apps.
10.09.20
7
min. Read
Five investors talk digital therapeutics: Red flags, starting up, and COVID–19
10.02.20
14
min. Read
Proteus founders explain. Investors talk DTx.
10.02.20
8
min. Read
Apple eyes asthma, sleep apnea SaMDs? Amwell-Teladongo suit.
9.18.20
8
min. Read
32 Pear patents. Amwell $644M IPO.
9.11.20
6
min. Read
New Teladongo merger details. Pear’s acquisitive study strategy.
9.04.20
8
min. Read
20 percent of Rx-only digital therapeutics have studies so far.
8.14.20
9
min. Read
Livongo’s IPO anniversary. DTx pipelines.
7.24.20
7
min. Read
Two UnitedHealth behavioral health acquisitions. BMS DTx launch Q3.
7.17.20
7
min. Read
265 PPP loans for digital health. Orexo Modia?
7.10.20
6
min. Read
1 of 23